Human Gene TRPV4 (uc001tpk.2)
  Description: Homo sapiens transient receptor potential cation channel, subfamily V, member 4 (TRPV4), transcript variant 1, mRNA.
RefSeq Summary (NM_021625): This gene encodes a member of the OSM9-like transient receptor potential channel (OTRPC) subfamily in the transient receptor potential (TRP) superfamily of ion channels. The encoded protein is a Ca2+-permeable, nonselective cation channel that is thought to be involved in the regulation of systemic osmotic pressure. Mutations in this gene are the cause of spondylometaphyseal and metatropic dysplasia and hereditary motor and sensory neuropathy type IIC. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Apr 2010].
Transcript (Including UTRs)
   Position: hg19 chr12:110,220,892-110,271,212 Size: 50,321 Total Exon Count: 16 Strand: -
Coding Region
   Position: hg19 chr12:110,221,426-110,252,601 Size: 31,176 Coding Exon Count: 15 

Page IndexSequence and LinksUniProtKB CommentsPrimersGenetic AssociationsMalaCards
CTDGene AllelesRNA-Seq ExpressionMicroarray ExpressionRNA StructureProtein Structure
Other SpeciesGO AnnotationsmRNA DescriptionsPathwaysOther NamesGeneReviews
Model InformationMethods
Data last updated at UCSC: 2013-06-14

-  Sequence and Links to Tools and Databases
 
Genomic Sequence (chr12:110,220,892-110,271,212)mRNA (may differ from genome)Protein (871 aa)
Gene SorterGenome BrowserOther Species FASTAVisiGeneGene interactionsTable Schema
AlphaFoldBioGPSEnsemblEntrez GeneExonPrimerGeneCards
GeneNetworkH-INVHGNCHPRDLynxMalacards
MGIneXtProtOMIMPubMedReactomeTreefam
UniProtKBWikipediaBioGrid CRISPR DB

-  Comments and Description Text from UniProtKB
  ID: TRPV4_HUMAN
DESCRIPTION: RecName: Full=Transient receptor potential cation channel subfamily V member 4; Short=TrpV4; AltName: Full=Osm-9-like TRP channel 4; Short=OTRPC4; AltName: Full=Transient receptor potential protein 12; Short=TRP12; AltName: Full=Vanilloid receptor-like channel 2; AltName: Full=Vanilloid receptor-like protein 2; Short=VRL-2; AltName: Full=Vanilloid receptor-related osmotically-activated channel; Short=VR-OAC;
FUNCTION: Non-selective calcium permeant cation channel probably involved in osmotic sensitivity and mechanosensitivity. Activation by exposure to hypotonicity within the physiological range exhibits an outward rectification. Also activated by low pH, citrate and phorbol esters. Increase of intracellular Ca(2+) potentiates currents. Channel activity seems to be regulated by a calmodulin-dependent mechanism with a negative feedback mechanism. Promotes cell-cell junction formation in skin keratinocytes and plays an important role in the formation and/or maintenance of functional intercellular barriers. Acts as a regulator of intracellular Ca(2+) in synoviocytes. Plays an obligatory role as a molecular component in the nonselective cation channel activation induced by 4-alpha-phorbol 12,13-didecanoate and hypotonic stimulation in synoviocytes and also regulates production of IL-8.
SUBUNIT: Homotetramer (Probable). Self-associates in a isoform- specific manner. Isoforms 1/A and 5/D but not isoform 2/B, 4/C and 6/E can oligomerize. Interacts with calmodulin. Interacts with Map7 and Src family Tyr protein kinases LYN, SRC, FYN, HCK, LCK and YES. Interacts with CTNNB1. The TRPV4 and CTNNB1 complex can interact with CDH1 (By similarity). Part of a complex containing MLC1, AQP4, HEPACAM and ATP1B1.
SUBCELLULAR LOCATION: Cell membrane; Multi-pass membrane protein (By similarity). Cell junction, adherens junction (By similarity). Note=Assembly of the putative homotetramer occurs primarily in the endoplasmic reticulum.
SUBCELLULAR LOCATION: Isoform 1: Cell membrane.
SUBCELLULAR LOCATION: Isoform 5: Cell membrane.
TISSUE SPECIFICITY: Found in the synoviocytes from patients with (RA) and without (CTR) rheumatoid arthritis (at protein level).
PTM: Phosphorylation results in enhancement of its channel function.
POLYMORPHISM: Genetic variations in TRPV4 determine the sodium serum level quantitative trait locus 1 (SSQTL1) [MIM:613508]. In some populations, variant Pro19Ser has been shown to be significantly associated with hyponatremia defined as serum sodium concentration below or equal to 135 mEq/L.
DISEASE: Defects in TRPV4 are the cause of brachyolmia type 3 (BRAC3) [MIM:113500]; also known as brachyrachia. The brachyolmias constitute a clinically and genetically heterogeneous group of skeletal dysplasias characterized by a short trunk, scoliosis and mild short stature. BRAC3 is an autosomal dominant form with severe kyphoscoliosis and flattened, irregular cervical vertebrae.
DISEASE: Defects in TRPV4 are the cause of spondylometaphyseal dysplasia Kozlowski type (SMDK) [MIM:184252]. The spondylometaphyseal dysplasias (SMDs) are a group of short-stature disorders distinguished by abnormalities in the vertebrae and the metaphyses of the tubular bones. SMDK is an autosomal dominant disorder characterized by significant scoliosis and mild metaphyseal abnormalities in the pelvis. The vertebrae exhibit platyspondyly and overfaced pedicles.
DISEASE: Defects in TRPV4 are the cause of metatropic dysplasia (MTD) [MIM:156530]; also called metatropic dwarfism. Metatropic dysplasia is a severe spondyloepimetaphyseal dysplasia characterized by short limbs with limitation and enlargement of joints and usually severe kyphoscoliosis. Radiologic features include severe platyspondyly, severe metaphyseal enlargement and shortening of long bones.
DISEASE: Defects in TRPV4 are the cause of distal spinal muscular atrophy congenital non-progressive (DSMAC) [MIM:600175]; a clinically variable, neuromuscular disorder characterized by congenital lower motor neuron disorder restricted to the lower part of the body. Clinical manifestations include non-progressive muscular atrophy, thigh muscle atrophy, weak thigh adductors, weak knee and foot extensors, minimal jaw muscle and neck flexor weakness, flexion contractures of knees and pes equinovarus. Tendon reflexes are normal.
DISEASE: Defects in TRPV4 are the cause of Charcot-Marie-Tooth disease type 2C (CMT2C) [MIM:606071]; an axonal form of Charcot- Marie-Tooth disease, a disorder of the peripheral nervous system, characterized by progressive weakness and atrophy, initially of the peroneal muscles and later of the distal muscles of the arms. Charcot-Marie-Tooth disease is classified in two main groups on the basis of electrophysiologic properties and histopathology: primary peripheral demyelinating neuropathies (designated CMT1 when they are dominantly inherited) and primary peripheral axonal neuropathies (CMT2). Neuropathies of the CMT2 group are characterized by signs of axonal regeneration in the absence of obvious myelin alterations, normal or slightly reduced nerve conduction velocities, and progressive distal muscle weakness and atrophy. Nerve conduction velocities are normal or slightly reduced.
DISEASE: Defects in TRPV4 are the cause of Scapuloperoneal spinal muscular atrophy (SPSMA) [MIM:181405]. It is a clinically variable neuromuscular disorder characterized by neurogenic scapuloperoneal amyotrophy, laryngeal palsy, congenital absence of muscles, progressive scapuloperoneal atrophy and progressive distal weakness and amyotrophy.
DISEASE: Defects in TRPV4 are the cause of spondyloepiphyseal dysplasia Maroteaux type (SEDM) [MIM:184095]. It is a clinically variable spondyloepiphyseal dysplasia with manifestations limited to the musculoskeletal system. Clinical features include short stature, brachydactyly, platyspondyly, short and stubby hands and feet, epiphyseal hypoplasia of the large joints, and iliac hypoplasia. Intelligence is normal.
DISEASE: Defects in TRPV4 are the cause of parastremmatic dwarfism (PSTD) [MIM:168400]. It is a bone dysplasia characterized by severe dwarfism, kyphoscoliosis, distortion and bowing of the extremities, and contractures of the large joints. Radiographically, the disease is characterized by a combination of decreased bone density, bowing of the long bones, platyspondyly and striking irregularities of endochondral ossification with areas of calcific stippling and streaking in radiolucent epiphyses, metaphyses and apophyses.
DISEASE: Defects in TRPV4 are the cause of digital arthropathy- brachydactyly, familial (FDAB) [MIM:606835]. A disorder characterized by irregularities in the proximal articular surfaces of the distal interphalangeal joints of the hand. Individuals appear normal at birth, with no clinical or radiographic evidence of a developmental skeletal dysplasia. The earliest changes appear during the first decade of life. By adulthood, all interphalangeal, metacarpophalangeal, and metatarsophalangeal joints are affected by a deforming, painful osteoarthritis. The remainder of the skeleton is clinically and radiographically unaffected.
SIMILARITY: Belongs to the transient receptor (TC 1.A.4) family. TrpV subfamily. TRPV4 sub-subfamily.
SIMILARITY: Contains 3 ANK repeats.

-  Primer design for this transcript
 

Primer3Plus can design qPCR Primers that straddle exon-exon-junctions, which amplify only cDNA, not genomic DNA.
Click here to load the transcript sequence and exon structure into Primer3Plus

Exonprimer can design one pair of Sanger sequencing primers around every exon, located in non-genic sequence.
Click here to open Exonprimer with this transcript

To design primers for a non-coding sequence, zoom to a region of interest and select from the drop-down menu: View > In External Tools > Primer3


-  Genetic Association Studies of Complex Diseases and Disorders
  Genetic Association Database (archive): TRPV4
CDC HuGE Published Literature: TRPV4
Positive Disease Associations: Platelet Count
Related Studies:
  1. Platelet Count
    , , . [PubMed 0]

-  MalaCards Disease Associations
  MalaCards Gene Search: TRPV4
Diseases sorted by gene-association score: metatropic dysplasia* (1702), spondylometaphyseal dysplasia, kozlowski type* (1692), scapuloperoneal spinal muscular atrophy* (1690), hereditary motor and sensory neuropathy, type iic* (1689), parastremmatic dwarfism* (1679), brachyolmia type 3* (1650), spinal muscular atrophy, distal, congenital nonprogressive* (1650), digital arthropathy-brachydactyly, familial* (1580), sed, maroteaux type* (1350), avascular necrosis of femoral head, primary, 2* (550), brachyolmia type 2* (500), brachyolmia* (447), skeletal dysplasia* (428), charcot-marie-tooth disease type 2c* (418), neuromuscular disease* (406), familial avascular necrosis of the femoral head* (247), roussy-levy syndrome* (151), charcot-marie-tooth disease* (148), digital arthropathy-brachydactyly* (130), progressive muscular atrophy (33), charcot-marie-tooth disease, axonal, type 2s* (32), arthropathy (21), muscular atrophy (14), avascular necrosis of the femoral head (14), spinal muscular atrophy (12), blount's disease (11), megalencephalic leukoencephalopathy with subcortical cysts (11), charcot-marie-tooth disease, axonal, type 2n (9), dwarfism (9), brachydactyly (8), axonal neuropathy (7), dentin sensitivity (7), achondrogenesis, type ii or hypochondrogenesis (7), pulmonary edema (7), hypochondrogenesis (7), subdural empyema (7), deafness, autosomal dominant 25 (7), metaphyseal chondrodysplasia, murk jansen type (6), skeletal dysplasias (6), tooth disease (5), kniest dysplasia (5), charcot-marie-tooth disease, type 4d (5), charcot-marie-tooth disease, axonal, type 2k (4), charcot-marie-tooth disease, type 2e (1), neuropathy, congenital hypomyelinating (1)
* = Manually curated disease association

-  Comparative Toxicogenomics Database (CTD)
  The following chemicals interact with this gene           more ... click here to view the complete list

+  Common Gene Haplotype Alleles
  Press "+" in the title bar above to open this section.

-  RNA-Seq Expression Data from GTEx (53 Tissues, 570 Donors)
  Highest median expression: 11.66 RPKM in Minor Salivary Gland
Total median expression: 66.54 RPKM



View in GTEx track of Genome Browser    View at GTEx portal     View GTEx Body Map

+  Microarray Expression Data
  Press "+" in the title bar above to open this section.

-  mRNA Secondary Structure of 3' and 5' UTRs
 
RegionFold EnergyBasesEnergy/Base
Display As
5' UTR -43.5089-0.489 Picture PostScript Text
3' UTR -233.40534-0.437 Picture PostScript Text

The RNAfold program from the Vienna RNA Package is used to perform the secondary structure predictions and folding calculations. The estimated folding energy is in kcal/mol. The more negative the energy, the more secondary structure the RNA is likely to have.

-  Protein Domain and Structure Information
  InterPro Domains: Graphical view of domain structure
IPR002110 - Ankyrin_rpt
IPR020683 - Ankyrin_rpt-contain_dom
IPR005821 - Ion_trans_dom
IPR004729 - TRP_channel
IPR008347 - TRPV1-4_channel
IPR008348 - TRPV4_channel
IPR024862 - TRPV_channel

Pfam Domains:
PF00023 - Ankyrin repeat
PF00520 - Ion transport protein

SCOP Domains:
48403 - Ankyrin repeat

Protein Data Bank (PDB) 3-D Structure
MuPIT help
4DX1 - X-ray MuPIT 4DX2 - X-ray MuPIT


ModBase Predicted Comparative 3D Structure on Q9HBA0
FrontTopSide
The pictures above may be empty if there is no ModBase structure for the protein. The ModBase structure frequently covers just a fragment of the protein. You may be asked to log onto ModBase the first time you click on the pictures. It is simplest after logging in to just click on the picture again to get to the specific info on that model.

-  Orthologous Genes in Other Species
  Orthologies between human, mouse, and rat are computed by taking the best BLASTP hit, and filtering out non-syntenic hits. For more distant species reciprocal-best BLASTP hits are used. Note that the absence of an ortholog in the table below may reflect incomplete annotations in the other species rather than a true absence of the orthologous gene.
MouseRatZebrafishD. melanogasterC. elegansS. cerevisiae
No orthologGenome BrowserGenome BrowserNo orthologNo orthologNo ortholog
Gene DetailsGene Details    
Gene SorterGene Sorter    
 RGDEnsembl   
 Protein SequenceProtein Sequence   
 AlignmentAlignment   

-  Gene Ontology (GO) Annotations with Structured Vocabulary
  Molecular Function:
GO:0000166 nucleotide binding
GO:0003779 actin binding
GO:0005034 osmosensor activity
GO:0005080 protein kinase C binding
GO:0005216 ion channel activity
GO:0005261 cation channel activity
GO:0005262 calcium channel activity
GO:0005515 protein binding
GO:0005516 calmodulin binding
GO:0005524 ATP binding
GO:0008017 microtubule binding
GO:0008289 lipid binding
GO:0015275 stretch-activated, cation-selective, calcium channel activity
GO:0019901 protein kinase binding
GO:0042169 SH2 domain binding
GO:0042802 identical protein binding
GO:0043014 alpha-tubulin binding
GO:0046872 metal ion binding
GO:0048487 beta-tubulin binding
GO:0051015 actin filament binding

Biological Process:
GO:0000122 negative regulation of transcription from RNA polymerase II promoter
GO:0002024 diet induced thermogenesis
GO:0006811 ion transport
GO:0006816 calcium ion transport
GO:0006874 cellular calcium ion homeostasis
GO:0006884 cell volume homeostasis
GO:0006970 response to osmotic stress
GO:0006971 hypotonic response
GO:0007015 actin filament organization
GO:0007043 cell-cell junction assembly
GO:0007204 positive regulation of cytosolic calcium ion concentration
GO:0007231 osmosensory signaling pathway
GO:0009612 response to mechanical stimulus
GO:0010628 positive regulation of gene expression
GO:0010759 positive regulation of macrophage chemotaxis
GO:0010977 negative regulation of neuron projection development
GO:0030103 vasopressin secretion
GO:0031117 positive regulation of microtubule depolymerization
GO:0031532 actin cytoskeleton reorganization
GO:0032868 response to insulin
GO:0034605 cellular response to heat
GO:0042538 hyperosmotic salinity response
GO:0042593 glucose homeostasis
GO:0043117 positive regulation of vascular permeability
GO:0043622 cortical microtubule organization
GO:0046330 positive regulation of JNK cascade
GO:0046785 microtubule polymerization
GO:0047484 regulation of response to osmotic stress
GO:0050729 positive regulation of inflammatory response
GO:0050891 multicellular organismal water homeostasis
GO:0055085 transmembrane transport
GO:0060351 cartilage development involved in endochondral bone morphogenesis
GO:0070374 positive regulation of ERK1 and ERK2 cascade
GO:0070509 calcium ion import
GO:0070588 calcium ion transmembrane transport
GO:0071470 cellular response to osmotic stress
GO:0071476 cellular hypotonic response
GO:0071477 cellular hypotonic salinity response
GO:0071639 positive regulation of monocyte chemotactic protein-1 production
GO:0071642 positive regulation of macrophage inflammatory protein 1 alpha production
GO:0071651 positive regulation of chemokine (C-C motif) ligand 5 production
GO:0097009 energy homeostasis
GO:0097497 blood vessel endothelial cell delamination
GO:1903444 negative regulation of brown fat cell differentiation
GO:1903759 signal transduction involved in regulation of aerobic respiration
GO:2000340 positive regulation of chemokine (C-X-C motif) ligand 1 production
GO:2000778 positive regulation of interleukin-6 secretion

Cellular Component:
GO:0005783 endoplasmic reticulum
GO:0005881 cytoplasmic microtubule
GO:0005886 plasma membrane
GO:0005887 integral component of plasma membrane
GO:0005912 adherens junction
GO:0005925 focal adhesion
GO:0005929 cilium
GO:0009986 cell surface
GO:0016020 membrane
GO:0016021 integral component of membrane
GO:0016324 apical plasma membrane
GO:0030027 lamellipodium
GO:0030054 cell junction
GO:0030175 filopodium
GO:0030426 growth cone
GO:0030864 cortical actin cytoskeleton
GO:0031410 cytoplasmic vesicle
GO:0032587 ruffle membrane
GO:0042995 cell projection


-  Descriptions from all associated GenBank mRNAs
  AB032427 - Homo sapiens VRL-2 mRNA for vanilloid receptor like channel-2, complete cds.
AL834192 - Homo sapiens mRNA; cDNA DKFZp762L026 (from clone DKFZp762L026).
AJ296305 - Homo sapiens mRNA for vanilloid receptor-like channel 2 (VRL2 gene).
AF263523 - Homo sapiens vanilloid receptor-related osmotically activated channel (VROAC) mRNA, complete cds.
BC117426 - Homo sapiens transient receptor potential cation channel, subfamily V, member 4, mRNA (cDNA clone MGC:151035 IMAGE:40125977), complete cds.
BC143307 - Homo sapiens cDNA clone IMAGE:9051812.
BC143315 - Homo sapiens transient receptor potential cation channel, subfamily V, member 4, mRNA (cDNA clone MGC:176837 IMAGE:9051820), complete cds.
AF279673 - Homo sapiens vanilloid receptor-like protein 2 (VRL2) mRNA, complete cds.
AB073669 - Homo sapiens mRNA for OTRPC4beta cation channel, complete cds.
AF258465 - Homo sapiens OTRPC4 mRNA, complete cds.
DQ059644 - Homo sapiens transient receptor potencial vanilloid 4 channel variant C (TRPV4) mRNA, complete cds.
DQ059645 - Homo sapiens transient receptor potencial vanilloid 4 channel variant D (TRPV4) mRNA, complete cds.
DQ059646 - Homo sapiens transient receptor potencial vanilloid 4 channel variant E (TRPV4) mRNA, complete cds.
AB590809 - Synthetic construct DNA, clone: pFN21AB8516, Homo sapiens TRPV4 gene for transient receptor potential cation channel, subfamily V, member 4, without stop codon, in Flexi system.
AB100308 - Homo sapiens TRPV-SV mRNA for hypothetical protein, complete cds.
JD193993 - Sequence 175017 from Patent EP1572962.
JD380713 - Sequence 361737 from Patent EP1572962.
JD060025 - Sequence 41049 from Patent EP1572962.
JD311539 - Sequence 292563 from Patent EP1572962.
JD439655 - Sequence 420679 from Patent EP1572962.
JD387842 - Sequence 368866 from Patent EP1572962.
JD157268 - Sequence 138292 from Patent EP1572962.
JD099444 - Sequence 80468 from Patent EP1572962.
JD065043 - Sequence 46067 from Patent EP1572962.
JD390454 - Sequence 371478 from Patent EP1572962.
JD132188 - Sequence 113212 from Patent EP1572962.
JD162042 - Sequence 143066 from Patent EP1572962.
JD393249 - Sequence 374273 from Patent EP1572962.
JD560580 - Sequence 541604 from Patent EP1572962.
JD287771 - Sequence 268795 from Patent EP1572962.
JD201115 - Sequence 182139 from Patent EP1572962.
JD104459 - Sequence 85483 from Patent EP1572962.
JD125057 - Sequence 106081 from Patent EP1572962.
JD342381 - Sequence 323405 from Patent EP1572962.
JD135129 - Sequence 116153 from Patent EP1572962.
JD194487 - Sequence 175511 from Patent EP1572962.
JD454000 - Sequence 435024 from Patent EP1572962.

-  Biochemical and Signaling Pathways
  BioCarta from NCI Cancer Genome Anatomy Project
h_raccPathway - Ion Channels and Their Functional Role in Vascular Endothelium

Reactome (by CSHL, EBI, and GO)

Protein Q9HBA0 (Reactome details) participates in the following event(s):

R-HSA-3295579 TRPs transport extracellular Ca2+ to cytosol
R-HSA-3295583 TRP channels
R-HSA-2672351 Stimuli-sensing channels
R-HSA-983712 Ion channel transport
R-HSA-382551 Transport of small molecules

-  Other Names for This Gene
  Alternate Gene Symbols: B7ZKQ6, NM_021625, NP_067638, Q17R79, Q2Y122, Q2Y123, Q2Y124, Q86YZ6, Q8NDY7, Q8NG64, Q96Q92, Q96RS7, Q9HBA0, Q9HBC0, TRPV4_HUMAN, VRL2, VROAC
UCSC ID: uc001tpk.2
RefSeq Accession: NM_021625
Protein: Q9HBA0 (aka TRPV4_HUMAN)
CCDS: CCDS9134.1, CCDS53829.1

-  GeneReviews for This Gene
  GeneReviews article(s) related to gene TRPV4:
cmt (Charcot-Marie-Tooth Hereditary Neuropathy Overview)
cmt2c (Autosomal Dominant TRPV4 Disorders)

-  Gene Model Information
 
category: coding nonsense-mediated-decay: no RNA accession: NM_021625.4
exon count: 16CDS single in 3' UTR: no RNA size: 3250
ORF size: 2616CDS single in intron: no Alignment % ID: 100.00
txCdsPredict score: 4873.00frame shift in genome: no % Coverage: 99.66
has start codon: yes stop codon in genome: no # of Alignments: 1
has end codon: yes retained intron: yes # AT/AC introns 0
selenocysteine: no end bleed into intron: 0# strange splices: 0
Click here for a detailed description of the fields of the table above.

-  Methods, Credits, and Use Restrictions
  Click here for details on how this gene model was made and data restrictions if any.